InventisBio

IPO

益方生物科技(上海)股份有限公司

InventisBio is a biotech company in Shanghai, China, founded in 2013. It has raised $247.0M across 4 rounds, most recently a $147.0M Series D in September 2020.

Headquarters
Shanghai, Shanghai
Employees
11–50
Founded
2013
Business Model
B2B
Total Funding
$247.0M
Last Round
$147.0M Series DSep 2020
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 10 investors for this company. to use credits for reveals, or explore the API.

About

InventisBio is a clinical-stage biotech company with two drugs approved and three candidates in clinical trials, with the most advanced in Phase 3 registration trials in China. Founded by scientists with extensive R&D experience at global pharmaceutical companies, the firm focuses on oncology, metabolic, and autoimmune diseases to address unmet medical needs, with headquarters in Shanghai Pudong and operations in New Jersey.

Funding History

Data from Indexed.vcUpdated
Series DSeries DSep 2020
$147.0M

3 more funding events

  • Series C20195 investors
  • Series B20172 investors
  • Series A2016

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Backend ×1
  • DevOps ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech
Private EquityTotal funding$2.3BFeb 2020
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech
Private EquityTotal funding$647.0MFeb 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech
Growth EquityTotal funding$2.7BJul 2026
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

InventisBio on Indexed.vc
<a href="https://indexed.vc/companies/inventisbio"><img src="https://indexed.vc/api/badge/company/inventisbio" alt="InventisBio on Indexed.vc" width="260" height="76" /></a>